Continuous cell programming devices

Details for Australian Patent Application No. 2009215188 (hide)

Owner Dana-Farber Cancer Institute, Inc. President and Fellows of Harvard College

Inventors Dranoff, Glenn; Ali, Omar; Mooney, David J.

Agent Freehills

Pub. Number AU-A-2009215188

PCT Pub. Number WO2009/102465

Priority 61/143,630 09.01.09 US; 61/065,672 13.02.08 US

Filing date 13 February 2009

Wipo publication date 20 August 2009

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

Event Publications

2 September 2010 PCT application entered the National Phase

  PCT publication WO2009/102465 Priority application(s): WO2009/102465

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009215191-6-aryl-imidaz0[l, 2-a] pyrazine derivatives, method of making, and method of use thereof

2009215178-Sprayer assembly with simultaneous control of on/off and flow selection